Serum glycoproteins in head and neck squamous carcinoma: correlations with tumor extent, clinical tumor stage, and T-cell levels during chemotherapy.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006258:Head and Neck Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D002955:Leucovorin / Q000008:administration & dosage / Q000627:therapeutic use; D007958:Leukocyte Count; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009367:Neoplasm Staging; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology*
D000970:Antineoplastic Agents; D006023:Glycoproteins; D001761:Bleomycin; D002945:Cisplatin; D002955:Leucovorin; D008727:Methotrexate